When:
Time: 8:00am PDT, 11:00am EDT, 4:00pm BST, 5:00pm CEST
Length: 60 minutes
Pharma organizations have an ever-increasing quantity of knowledge that can be utilized in drug discovery. With 80% of all knowledge in unstructured codecs, organizations want modern applied sciences to untap the potential worth of those knowledge streams. Deploying pure language processing (NLP) at scale is essential to tremendously growing knowledge entry and knowledge insights.
Be a part of us to learn the way NLP may help enhance the speed-to-insight technology 10-100X. We’ll cowl how we’re utilizing the newest AI/ML applied sciences and a number of other examples of how our shoppers, equivalent to Roche and Sanofi, are using our platform. We’ll go over quite a lot of use circumstances together with:
- Goal identification
- Drug discovery
- Precision drugs
Audio system
Constantinos Katevatis
Associate Director, R&D NLP
Constantinos Katevatis is Affiliate Director, R&D NLP at Linguamatics, an IQVIA firm. He’s chargeable for creating the strategic imaginative and prescient of Linguamatics’ product portfolio and enterprise improvement for R&D and medical operations within the pharma and biotech industries. Constantinos has expertise and experience in NLP-centric knowledge extraction and knowledge administration throughout the pharma product life cycle. Earlier than becoming a member of the life science business, Constantinos accomplished a doctorate on DNA-based medical units.
Peng Zhang
Senior Application Scientist
Peng Zhang is a Senior Software Scientist who offers NLP options for extracting data from unstructured knowledge equivalent to scientific literatures, digital medical information and actual world evidences. Earlier than becoming a member of Linguamatics, he had >10 years’ expertise of text-mining and informatics in pharmaceutical and biotechnology R&D setting.